Lemon Balm (Melissa officinalis).

L-theanine crosses into the brain and shifts glutamate and GABA signalling toward a relaxed but alert state, while lemon balm slows GABA breakdown by inhibiting GABA transaminase. The two act at different points of the same system, so they are paired for daytime calm without sedation.

Apigenin from chamomile binds the benzodiazepine site of the GABA-A receptor, and lemon balm raises GABA availability by inhibiting the enzyme that degrades it. Receptor binding plus more of the ligand is the mechanistic logic behind a pairing that predates the supplement category.

Passionflower flavonoids modulate GABA-A receptors and reduce GABA uptake, and lemon balm slows GABA degradation. Both act on the same inhibitory system, which is why European calming blends rarely carry one without the other.

Magnesium dampens NMDA channel activity and supports GABA-A function, and its glycine carrier is itself an inhibitory neurotransmitter. That sits alongside lemon balm's effect on GABA turnover.

Melatonin acts on MT1 and MT2 receptors to time the sleep phase while lemon balm works through GABAergic tone. The two do not compete for the same receptor.

Glycine is an inhibitory neurotransmitter at its own strychnine sensitive receptor and lowers core temperature before sleep. It adds a distinct inhibitory route to lemon balm's GABAergic one.

Apigenin is the chamomile flavone that binds the benzodiazepine site of the GABA-A receptor as a partial ligand. Lemon balm instead slows GABA catabolism, so the two converge on the same channel from different sides.

Honokiol and magnolol act as positive modulators at the GABA-A receptor. Combined with lemon balm's slowed GABA breakdown the inhibitory effect is additive and should be dosed with that in mind.

Kavalactones modulate GABA-A channels and sodium channel activity, which overlaps with lemon balm's inhibitory effect. The combined calming effect is additive, so total load matters more than either dose alone.

Rosemary and lemon balm both carry rosmarinic acid, the constituent linked to GABA transaminase inhibition. Their contributions to the same polyphenol should be summed rather than listed separately.

A phospholipid-complexed Melissa preparation was studied in adults for sleep quality and mental well-being, and the authors report improvement on their measures. Complexing a polar phenolic extract with phospholipid changes how it disperses and is absorbed. The result belongs to that specific complexed form rather than to a plain leaf extract.

Phosphatidylcholine is the phospholipid used to complex polyphenol-rich extracts, forming an amphiphilic assembly that carries a water-soluble phenolic across a lipid membrane more readily. Rosmarinic acid is a good candidate for that approach because it absorbs poorly on its own. The mechanism is delivery, not added activity.

Rosmarinic acid inhibits GABA transaminase in vitro, the enzyme that breaks GABA down, so the extract acts on GABA availability while a supplemental dose supplies the molecule itself. The two sit at supply and at breakdown. Oral GABA crosses into the brain poorly, so most of its action is likely peripheral.

Tryptophan is the substrate for serotonin and then melatonin, a pathway lemon balm's phenolics do not feed. Combining them puts substrate supply next to a GABAergic mechanism. Supplying a precursor only changes anything where substrate is what limits the pathway.

5-HTP is the immediate precursor to serotonin and bypasses the rate-limiting hydroxylation step that tryptophan must pass through. It brings a different pathway from the GABA-directed one. It needs pyridoxal 5-phosphate for the decarboxylation, so B6 status is part of the picture.

Pyridoxal 5-phosphate is the cofactor for glutamate decarboxylase, which makes GABA, and for aromatic L-amino acid decarboxylase, which makes serotonin. It is also the cofactor for GABA transaminase, the enzyme rosmarinic acid inhibits, so B6 sits on both sides of that reaction. This is settled cofactor biochemistry.

Taurine is an agonist at glycine receptors and a weak agonist at GABA-A, adding a receptor-level action beside an enzyme-level one. It also stabilises intracellular calcium handling. The pairing is mechanistic; no trial has measured the two together.

Salivary cortisol dynamics were tracked in adults receiving a phospholipid-based Melissa preparation alongside sleep and well-being measures, so the endocrine axis is one this ingredient has been examined against. Cortisol is a marker and the study relates it to reported measures rather than demonstrating cause. Phosphatidylserine is used for the same axis by a separate route.

Rosmarinic acid is the principal phenolic of Melissa leaf and the marker most extracts are standardised on, so an isolated rosmarinic acid dose and a standardised extract share their main active. Supplying it separately does not reproduce the flavonoid and volatile fraction of the whole leaf. Read the two as overlapping rather than complementary.

Caffeine blocks adenosine receptors and raises arousal, working directly against an ingredient taken for calm or for sleep onset. Its half-life of several hours means an afternoon dose is still present at bedtime. The opposition is predictable and mostly a timing problem.

Ginkgo is used for cerebral perfusion and cognitive support, a vascular route rather than a neurotransmitter one, and lemon balm is combined with it in daytime cognition formulas. Ginkgo also affects platelet aggregation, which is worth counting in a stack. No study has tested this specific pair.

Bacopa builds its effect over weeks of continuous dosing while lemon balm has been examined for acute effects on mood and cognitive performance. The two therefore cover different timescales in one product. The pairing is formulation convention, not a tested combination.

Melissa and peppermint are both Lamiaceae carminatives and appear together in traditional digestive and calming teas. The volatile fractions differ, with menthol dominating one and citral the other. This is a long-standing culinary and herbal pairing rather than a studied combination.

Both extracts deliver polyphenols cleared through the same glucuronidation and sulfation enzymes, so stacking them widens the phenolic pool while competing for finite conjugation capacity. Any caffeine in the green tea material pulls in the opposite direction from lemon balm's calming use. Decaffeinated extracts remove that conflict.

Rosmarinic acid is poorly absorbed intact and is hydrolysed by gut bacteria to caffeic acid and then to smaller phenolics that reach the circulation. The composition of the microbiota therefore sets how much of an oral dose is ever seen systemically. Which strains do this and how much varies between people.

Ascorbate regenerates phenoxyl radicals formed when polyphenols quench a radical, returning the phenolic to its reduced state in model systems. That places lemon balm's phenolics and vitamin C in one recycling network. The demonstration is chemical and in vitro, so read it as mechanistic rather than clinical.

Phenolic acids and flavonoids bind non-heme iron in the gut lumen and lower the fraction available for uptake, which is why strong herbal infusions are kept away from an iron dose. Lemon balm's phenolic load is high enough for this to apply. Separating the two by a couple of hours is the standard answer.